2023-11-082024-11-302024-11-30false15268569DR ANNA MORRIS HAEMATOLOGIST LIMITED2025-03-07falseiso4217:GBPxbrli:pure152685692023-11-08152685692024-11-30152685692023-11-082024-11-30152685692023-11-07152685692023-11-07152685692023-11-072023-11-0715268569bus:SmallEntities2023-11-082024-11-3015268569bus:AuditExempt-NoAccountantsReport2023-11-082024-11-3015268569bus:AbridgedAccounts2023-11-082024-11-3015268569bus:PrivateLimitedCompanyLtd2023-11-082024-11-3015268569core:WithinOneYear2024-11-3015268569core:AfterOneYear2024-11-3015268569core:WithinOneYear2023-11-0715268569core:AfterOneYear2023-11-0715268569core:ShareCapital2024-11-3015268569core:SharePremium2024-11-3015268569core:RevaluationReserve2024-11-3015268569core:OtherReservesSubtotal2024-11-3015268569core:RetainedEarningsAccumulatedLosses2024-11-3015268569core:ShareCapital2023-11-0715268569core:SharePremium2023-11-0715268569core:RevaluationReserve2023-11-0715268569core:OtherReservesSubtotal2023-11-0715268569core:RetainedEarningsAccumulatedLosses2023-11-0715268569core:LandBuildings2024-11-3015268569core:PlantMachinery2024-11-3015268569core:Vehicles2024-11-3015268569core:FurnitureFittings2024-11-3015268569core:OfficeEquipment2024-11-3015268569core:NetGoodwill2024-11-3015268569core:IntangibleAssetsOtherThanGoodwill2024-11-3015268569core:ListedExchangeTraded2024-11-3015268569core:UnlistedNon-exchangeTraded2024-11-3015268569core:LandBuildings2023-11-0715268569core:PlantMachinery2023-11-0715268569core:Vehicles2023-11-0715268569core:FurnitureFittings2023-11-0715268569core:OfficeEquipment2023-11-0715268569core:NetGoodwill2023-11-0715268569core:IntangibleAssetsOtherThanGoodwill2023-11-0715268569core:ListedExchangeTraded2023-11-0715268569core:UnlistedNon-exchangeTraded2023-11-0715268569core:LandBuildings2023-11-082024-11-3015268569core:PlantMachinery2023-11-082024-11-3015268569core:Vehicles2023-11-082024-11-3015268569core:FurnitureFittings2023-11-082024-11-3015268569core:OfficeEquipment2023-11-082024-11-3015268569core:NetGoodwill2023-11-082024-11-3015268569core:IntangibleAssetsOtherThanGoodwill2023-11-082024-11-3015268569core:ListedExchangeTraded2023-11-082024-11-3015268569core:UnlistedNon-exchangeTraded2023-11-082024-11-3015268569core:MoreThanFiveYears2023-11-082024-11-3015268569core:Non-currentFinancialInstruments2024-11-3015268569core:Non-currentFinancialInstruments2023-11-0715268569dpl:CostSales2023-11-082024-11-3015268569dpl:DistributionCosts2023-11-082024-11-3015268569core:LandBuildings2023-11-082024-11-3015268569core:PlantMachinery2023-11-082024-11-3015268569core:Vehicles2023-11-082024-11-3015268569core:FurnitureFittings2023-11-082024-11-3015268569core:OfficeEquipment2023-11-082024-11-3015268569dpl:AdministrativeExpenses2023-11-082024-11-3015268569core:NetGoodwill2023-11-082024-11-3015268569core:IntangibleAssetsOtherThanGoodwill2023-11-082024-11-3015268569dpl:GroupUndertakings2023-11-082024-11-3015268569dpl:ParticipatingInterests2023-11-082024-11-3015268569dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-082024-11-3015268569core:ListedExchangeTraded2023-11-082024-11-3015268569dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-082024-11-3015268569core:UnlistedNon-exchangeTraded2023-11-082024-11-3015268569dpl:CostSales2023-11-072023-11-0715268569dpl:DistributionCosts2023-11-072023-11-0715268569core:LandBuildings2023-11-072023-11-0715268569core:PlantMachinery2023-11-072023-11-0715268569core:Vehicles2023-11-072023-11-0715268569core:FurnitureFittings2023-11-072023-11-0715268569core:OfficeEquipment2023-11-072023-11-0715268569dpl:AdministrativeExpenses2023-11-072023-11-0715268569core:NetGoodwill2023-11-072023-11-0715268569core:IntangibleAssetsOtherThanGoodwill2023-11-072023-11-0715268569dpl:GroupUndertakings2023-11-072023-11-0715268569dpl:ParticipatingInterests2023-11-072023-11-0715268569dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-072023-11-0715268569core:ListedExchangeTraded2023-11-072023-11-0715268569dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-072023-11-0715268569core:UnlistedNon-exchangeTraded2023-11-072023-11-0715268569core:NetGoodwill2024-11-3015268569core:IntangibleAssetsOtherThanGoodwill2024-11-3015268569core:LandBuildings2024-11-3015268569core:PlantMachinery2024-11-3015268569core:Vehicles2024-11-3015268569core:FurnitureFittings2024-11-3015268569core:OfficeEquipment2024-11-3015268569core:AfterOneYear2024-11-3015268569core:WithinOneYear2024-11-3015268569core:ListedExchangeTraded2024-11-3015268569core:UnlistedNon-exchangeTraded2024-11-3015268569core:ShareCapital2024-11-3015268569core:SharePremium2024-11-3015268569core:RevaluationReserve2024-11-3015268569core:OtherReservesSubtotal2024-11-3015268569core:RetainedEarningsAccumulatedLosses2024-11-3015268569core:NetGoodwill2023-11-0715268569core:IntangibleAssetsOtherThanGoodwill2023-11-0715268569core:LandBuildings2023-11-0715268569core:PlantMachinery2023-11-0715268569core:Vehicles2023-11-0715268569core:FurnitureFittings2023-11-0715268569core:OfficeEquipment2023-11-0715268569core:AfterOneYear2023-11-0715268569core:WithinOneYear2023-11-0715268569core:ListedExchangeTraded2023-11-0715268569core:UnlistedNon-exchangeTraded2023-11-0715268569core:ShareCapital2023-11-0715268569core:SharePremium2023-11-0715268569core:RevaluationReserve2023-11-0715268569core:OtherReservesSubtotal2023-11-0715268569core:RetainedEarningsAccumulatedLosses2023-11-0715268569core:NetGoodwill2023-11-0715268569core:IntangibleAssetsOtherThanGoodwill2023-11-0715268569core:LandBuildings2023-11-0715268569core:PlantMachinery2023-11-0715268569core:Vehicles2023-11-0715268569core:FurnitureFittings2023-11-0715268569core:OfficeEquipment2023-11-0715268569core:AfterOneYear2023-11-0715268569core:WithinOneYear2023-11-0715268569core:ListedExchangeTraded2023-11-0715268569core:UnlistedNon-exchangeTraded2023-11-0715268569core:ShareCapital2023-11-0715268569core:SharePremium2023-11-0715268569core:RevaluationReserve2023-11-0715268569core:OtherReservesSubtotal2023-11-0715268569core:RetainedEarningsAccumulatedLosses2023-11-0715268569core:AfterOneYear2023-11-082024-11-3015268569core:WithinOneYear2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:CostValuation2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-082024-11-3015268569core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3015268569core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3015268569core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3015268569core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3015268569core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3015268569core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3015268569core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3015268569core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3015268569core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3015268569core:Non-currentFinancialInstrumentscore:CostValuation2023-11-0715268569core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-0715268569core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-0715268569core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-0715268569core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-0715268569core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-0715268569core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-0715268569core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-0715268569core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-0715268569bus:Director12023-11-082024-11-3015268569bus:Director22023-11-082024-11-30

DR ANNA MORRIS HAEMATOLOGIST LIMITED

Registered Number
15268569
(England and Wales)

Unaudited Financial Statements for the Period ended
30 November 2024

DR ANNA MORRIS HAEMATOLOGIST LIMITED
Company Information
for the period from 8 November 2023 to 30 November 2024

Directors

ROBERTSON, Anna Katharine
ROBERTSON, John Alexander

Registered Address

Kumar Associates
28a The Hundred
Romsey
SO51 8BW

Registered Number

15268569 (England and Wales)
DR ANNA MORRIS HAEMATOLOGIST LIMITED
Balance Sheet as at
30 November 2024

Notes

2024

£

£

Current assets
Debtors3730
Cash at bank and on hand3,757
4,487
Creditors amounts falling due within one year4(3,803)
Net current assets (liabilities)684
Total assets less current liabilities684
Net assets684
Capital and reserves
Called up share capital150
Profit and loss account534
Shareholders' funds684
The financial statements were approved and authorised for issue by the Board of Directors on 7 March 2025, and are signed on its behalf by:
ROBERTSON, Anna Katharine
Director
Registered Company No. 15268569
DR ANNA MORRIS HAEMATOLOGIST LIMITED
Notes to the Financial Statements
for the period ended 30 November 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

2024
Average number of employees during the year0
3.Debtors: amounts due within one year

2024

£
Trade debtors / trade receivables730
Total730
4.Creditors: amounts due within one year

2024

£
Taxation and social security592
Other creditors2,490
Accrued liabilities and deferred income721
Total3,803